SCHEMBL5779986

SCHEMBL5779986

C=CCC(N=C(c1ccccc1)c1ccccc1)C(=O)O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 2/20 0.49
KDM4E B2RXH2 2/20 0.42
AAK1 Q2M2I8 1/20 0.42
AKT1 P31749 1/20 0.40
ALDH1A1 P00352 4/20 0.37
LMNA P02545 2/20 0.37
HPGD P15428 2/20 0.37
TBXAS1 P24557 1/20 0.37
TSHR P16473 4/20 0.37
SMN1; SMN2 Q16637 3/20 0.36
RAB9A P51151 1/20 0.36
PPARG P37231 1/20 0.35
PPARA Q07869 1/20 0.35
L3MBTL1 Q9Y468 3/20 0.35
MAPT P10636 3/20 0.35
TDP1 Q9NUW8 3/20 0.35
POLB P06746 2/20 0.35
CYP3A4 P08684 2/20 0.35
PARP1 P09874 1/20 0.35
RECQL P46063 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5779979 1.00 CYP2C19 (0.49) CYP2C19KDM4EAAK1AKT1ALDH1A1
SCHEMBL5779984 1.00 CYP2C19 (0.49) CYP2C19KDM4EAAK1AKT1ALDH1A1
SCHEMBL13950541 0.82 MEN1 (0.46) CYP2C19KDM4EAAK1ALDH1A1TBXAS1
SCHEMBL17896140 0.81 AAK1 (0.43) AAK1AKT1ALDH1A1LMNATSHR
SCHEMBL17896141 0.81 AAK1 (0.43) AAK1AKT1ALDH1A1LMNATSHR
SCHEMBL22754552 0.80 AAK1 (0.65) CYP2C19KDM4EAAK1ALDH1A1HPGD
SCHEMBL22754571 0.80 AAK1 (0.65) CYP2C19KDM4EAAK1ALDH1A1HPGD
SCHEMBL22754553 0.80 AAK1 (0.65) CYP2C19KDM4EAAK1ALDH1A1HPGD
SCHEMBL381892 0.77 AAK1 (0.48) CYP2C19AAK1ALDH1A1LMNATSHR
SCHEMBL2560172 0.77 AAK1 (0.44) CYP2C19KDM4EAAK1ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060128956-A1 (Purin-6-yl) amino acid and production method thereof USTAV ORGANICKE CHEMIE A BIOCHEMIE AKADEMIE VED CESKE REPUBLIKY (CZ) 2006-06-15 US disclosed
EP-1615926-A1 (PURIN-6-YL) AMINO ACID AND PRODUCTION METHOD THEREOF Ustav Organicke Chemie A Biochemie Akademie Ved Ceske Republiky (CZ) 2006-01-18 EP disclosed
WO-2004094426-A1 (PURIN-6-YL) AMINO ACID AND PRODUCTION METHOD THEREOF USTAV ORGANICKÉ CHEMIE A BIOCHEMIE AKADEMIE VED CESKÉ REPUBLIKY (CZ) 2004-11-04 WO disclosed
EP-0047516-B1 PROPYLAMINE DERIVATIVE AND PROCESS OF MANUFACTURING THE SAME TORAY INDUSTRIES, INC. (JP) 1984-01-04 EP disclosed
EP-0047516-A1 Propylamine derivative and process of manufacturing the same TORAY INDUSTRIES, INC. (JP) 1982-03-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060128956-A1 (Purin-6-yl) amino acid and production method thereof PRPF3, PURB, PRPF31 CYP2C19 4041/4885KDM4E 1490/4885AAK1 4457/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.